The influence of persistent organ damage on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients

被引：0

作者：

Magro, F. ^{[1
,2
,3
,4
,5
]}

Fernandes, S. ^{[6
,7
]}

Patita, M. ^{[8
]}

Arroja, B. ^{[9
]}

Lago, P. ^{[10
]}

Rosa, I. ^{[11
]}

De Sousa, H. Tavares ^{[12
,13
]}

Ministro, P. ^{[2
]}

Mocanu, I.

Vieira, A.

Castela, J.

Moleiro, J. ^{[15
]}

Roseira, J.

Cancela, E.

Sousa, P. ^{[14
]}

Portela, F. ^{[2
,16
]}

Correia, L. ^{[2
,17
]}

Moreira, P. ^{[3
]}

Afonso, J. ^{[2
]}

Dias, S. ^{[2
]}

Danese, S. ^{[18
,19
]}

Peyrin-Biroulet, L. ^{[20
,21
]}

Vucicevic, K. ^{[22
]}

Santiago, M. ^{[2
]}

机构：

[1] Sao Joao Hosp Univ Ctr, Gastroenterol Dept, Porto, Portugal

[2] Gedii, Portuguese Grp Studies Inflammatory Bowel Dis, Porto, Portugal

[3] Sao Joao Hosp Univ Ctr, Clin Pharmacol Unit, Porto, Portugal

[4] Univ Porto, Ctr Hlth Technol & Serv Res Hlth Res Network CINT, Fac Med, Porto, Portugal

[5] Univ Porto, Dept Biomed, Fac Med, Unit Pharmacol & Therapeut, Porto, Portugal

[6] Northern Lisbon Univ Ctr, Gastroenterol Dept, Lisbon, Portugal

[7] Med Univ Lisbon, Clin Univ Gastrenterol, Lisbon, Portugal

[8] Garcia Orta Hosp, Gastroenterol Dept, Lisbon, Portugal

[9] Braga Hosp, Gastroenterol Dept, Braga, Portugal

[10] Porto Hosp Univ Ctr, Gastroenterol Dept, Porto, Portugal

[11] IPOLFG, Gastroenterol Dept, Lisbon, Portugal

[12] Algarve Hosp Univ Ctr, Gastroenterol Dept, Portimao Unit, Portimao, Portugal

[13] Univ Algarve, ABC Algarve Biomed Ctr, Faro, Portugal

[14] Viseu Tondela Hosp Ctr, Gastroenterol Dept, Viseu, Portugal

[15] IPOLFG, Gastroenterol Dept, Lisbon, Portugal

[16] Coimbra Hosp Univ Ctr, Gastroenterol Dept, Coimbra, Portugal

[17] Northern Lisbon Univ Hosp Ctr, Gastroenterol Dept, Lisbon, Portugal

[18] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[19] Humanitas Res Hosp, IRCCS, IBD Ctr, Milan, Italy

[20] Univ Lorraine, Univ Hosp Nancy, Dept Gastroenterol, Nancy, France

[21] Inserm NGERE U1256, Nancy, France

[22] Univ Belgrade, Dept Pharmacokinet & Clin Pharm, Belgrade, Serbia

来源：

JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P430

引用

页码：I875 / I876

页数：2

共 50 条

[1] THE INFLUENCE OF PERSISTENT ACTIVE INFLAMMATION ON IFX PHARMACOKINETIC MODELING AND DISEASE PROGRESSION ASSESSMENT: FINDINGS FROM A PROSPECTIVE REAL-WORLD STUDY IN INFLAMMATORY BOWEL DISEASE PATIENTS
Magro, Fernando
Fernandes, Samuel R.
Patita, Marta
Arroja, Bruno
Lago, Paula M.
Rosa, Isadora
Sousa, Helena Tavares
Ministro, Paula
Mocanu, Irina
Vieira, Ana
Castela, Joana
Moleiro, Joana
Roseira, Joana
Cancela, Eugenia
Sousa, Paula
Portela, Francisco
Correia, Luis Araujo
Moreira, Paula
Afonso, Joana
Dias, Sandra
Danese, Silvio
Peyrin-Biroulet, Laurent
Vucicevic, Katarina
Santiago, Mafalda
GASTROENTEROLOGY, 2024, 166 (05) : S1141 - S1141
[2] The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients
Magro, Fernando
Fernandes, Samuel
Patita, Marta
Arroja, Bruno
Lago, Paula
Rosa, Isadora
de Sousa, Helena Tavares
Ministro, Paula
Mocanu, Irina
Vieira, Ana
Castela, Joana
Moleiro, Joana
Roseira, Joana
Cancela, Eugenia
Sousa, Paula
Portela, Francisco
Correia, Luis
Moreira, Paula
Dias, Sandra
Afonso, Joana
Danese, Silvio
Peyrin-Biroulet, Laurent
Vucicevic, Katarina M.
Santiago, Mafalda
JOURNAL OF CROHNS & COLITIS, 2024, 18 (07): : 1102 - 1112
[3] Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY
Cleveland, Noa Krugliak
Ghosh, Sabyasachi
Chastek, Benjamin
Bancroft, Tim
Candela, Ninfa
Fan, Tao
Umashankar, Kandavadivu
Rubin, David T.
INFLAMMATORY BOWEL DISEASES, 2023, 30 (10) : 1776 - 1787
[4] Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
Markovic, S.
Kralj, D.
Ivanovski, T. Knezevic
Kalaba, A.
Odanovic, O.
Homsek, A.
Svorcan, P.
Vucicevic, K.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1231 - I1231
[5] Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience
Cleveland, Noa Krugliak
Choi, Natalie
Choi, David K.
Dalal, Sushila
Rubin, David T.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S873 - S874
[6] SUBCLINICAL PERSISTENT INFLAMMATION AS RISK FACTOR FOR CROHN'S DISEASE PROGRESSION: FINDINGS FROM A PROSPECTIVE REAL-WORLD STUDY OF 2 YEARS
Magro, Fernando
Magalhaes, Diogo
Patita, Marta
Arroja, Bruno
Lago, Paula M.
Rosa, Isadora
Sousa, Helena Tavares
Ministro, Paula
Mocanu, Irina
Vieira, Ana
Castela, Joana
Moleiro, Joana
Roseira, Joana
Cancela, Eugenia M.
Sousa, Paula
Portela, Francisco
Correia, Luis Araujo
Santiago, Mafalda
Dias, Sandra
Alves, Catarina
Afonso, Joana
Danese, Silvio
Peyrin-Biroulet, Laurent
Dias, Camila
GASTROENTEROLOGY, 2022, 162 (07) : S617 - S617
[7] Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years
Magro, Fernando
Magalhaes, Diogo
Patita, Marta
Arroja, Bruno
Lago, Paula
Rosa, Isadora
de Sousa, Helena Tavares
Ministro, Paula
Mocanu, Irinia
Vieira, Ana
Castela, Joana
Moleiro, Joana
Roseira, Joana
Cancela, Eugenia
Sousa, Paula
Portela, Francisco
Correia, Luis
Santiago, Mafalda
Dias, Sandra
Alves, Catarina
Afonso, Joana
Danese, Silvio
Peyrin-Biroulet, Laurent
Dias, Claudia Camila
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (09) : 2059 - +
[8] Osteoporosis, osteopenia, and inflammatory bowel disease: lessons from a real-world study
Pellicano, Rinaldo
Ribaldone, Davide G.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (7-8): : 411 - 413
[9] Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study
Thomas, Pepijn W. A.
den Broeder, Nathan
Derikx, Monique
Kievit, Wietske
West, Rachel L.
Russel, Maurice G. V. M.
Jansen, Jeroen M.
Romkens, Tessa E. H.
Hoentjen, Frank
INFLAMMATORY BOWEL DISEASES, 2022, 28 (12) : 1813 - 1820
[10] Prospective outcome following ustekinumab treatment in a real-world cohort of inflammatory bowel disease patients
Lopez, L. Ramos
Ramos-Diaz, R.
Benitez-Zafra, F.
Morant-Dominguez, A.
Vera-Santana, B.
Mourani-Padron, I.
Alonso-Abreu, I.
Carrillo-Palau, M.
Reygosa, C.
Medina-Chico, J. S.
Gutierrez-Nicolas, F.
Nazco-Casariego, J.
Hernandez-Guerra, M.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1587 - I1588

← 1 2 3 4 5 →